1. Zeaxanthin Dipalmitate in the Treatment of Liver Disease
    Nisma Lena Bahaji Azami et al, 2019, Evidence-Based Complementary and Alternative Medicine CrossRef
  2. A Candidate Drug for Nonalcoholic Fatty Liver Disease: A Review of Pharmacological Activities of Polygoni Multiflori Radix
    Mengting Zhou et al, 2020, BioMed Research International CrossRef
  3. Therapeutic Potential of Emodin for Gastrointestinal Cancers
    Sierra J. McDonald et al, 2022, Integrative Cancer Therapies CrossRef
  4. Network Pharmacological Analysis and Experimental Validation of the Mechanisms of Action of Si-Ni-San Against Liver Fibrosis
    Siliang Wang et al, 2021, Frontiers in Pharmacology CrossRef
  5. Emodin promotes hepatic stellate cell senescence and alleviates liver fibrosis via a nuclear receptor (Nur77)‐mediated epigenetic regulation of glutaminase 1
    Li Chen et al, 2023, British Journal of Pharmacology CrossRef
  6. Semi-synthetic product dihydroartemisinin inhibited fibronectin-1 and integrin-β1 and interfered with the migration of HCCLM6 cells via PI3K-AKT pathway
    Ruiting Wu et al, 2020, Biotechnology Letters CrossRef
  7. HEPATOCELLULAR TOXICITY OF THE METABOLITE EMODIN PRODUCED BY THE COMMON BUCKTHORN (RHAMNUS CATHARTICA) IN GREEN FROG (LITHOBATES CLAMITANS) TADPOLES
    Roberto Brenes et al, 2022, Journal of Wildlife Diseases CrossRef
  8. Kanglexin protects against cardiac fibrosis and dysfunction in mice by TGF-β1/ERK1/2 noncanonical pathway
    Xue Liu et al, 2021, Frontiers in Pharmacology CrossRef

  9. Emodin Retarded Renal Fibrosis Through Regulating HGF and TGFβ–Smad Signaling Pathway


    Fan Yang et al, 2020, Drug Design, Development and Therapy CrossRef
  10. Role and Mechanism of Epithelial-Mesenchymal Transition Mediated by Inflammatory Stress-Induced TGF-β1 in Promoting Arteriovenous Fistula Stenosis
    Qingqing Duan et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
  11. Traditional Chinese medicine: An important source for discovering candidate agents against hepatic fibrosis
    Wen-Qing Li et al, 2022, Frontiers in Pharmacology CrossRef
  12. Herbal Compounds in the Treatment of Pulmonary Silicosis
    J ADAMCAKOVA et al, 2021, Physiological Research CrossRef
  13. Herbal Compounds in the Treatment of Pulmonary Silicosis
    J ADAMCAKOVA et al, 2021, Physiological Research CrossRef
  14. The Potential Application of Chinese Medicine in Liver Diseases: A New Opportunity
    Ke Fu et al, 2021, Frontiers in Pharmacology CrossRef